{
  "schema_version": "0.1.0",
  "case_id": "HR-ML037",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML037",
    "display_name": "Jackie Robinson",
    "aliases": [],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1919-01-31",
          "display": "January 31, 1919",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1919",
              "display": "1919",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with SABR and the California legislature."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1972-10-24",
          "display": "October 24, 1972",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1972-10-23",
              "display": "October 23, 1972",
              "precision": "day",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0005"
            ],
            "resolution_status": "conflicting",
            "note": "Given by the Dodgers timeline; SABR, the California legislature and the University of California article give October 24."
          },
          {
            "date": {
              "iso": "1972",
              "display": "1972",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML037-SYN",
      "ssn": "000-37-2286",
      "date_of_birth": "1974-01-31",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Marcus Delacroix-Hale, MD",
      "fictional_consultant": {
        "name": "Priya Ostrowski-Lane, MD",
        "specialty": "Ophthalmology (retina)"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1919-01-31",
        "display": "January 31, 1919",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Cairo, Georgia.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1947-04-15",
        "display": "April 15, 1947",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "First major league game, for the Brooklyn Dodgers.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1957",
        "display": "1957",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Retirement from baseball announced; diabetes diagnosed at about this time.",
      "claim_ids": [
        "CLM-0003",
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1969",
        "display": "1969",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Nerve and artery damage in his legs by this year.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1970",
        "display": "1970",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Two mild strokes.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1971-06-17",
        "display": "June 17, 1971",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "His eldest son killed in an automobile accident.",
      "claim_ids": [
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1972",
        "display": "1972",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Nearly blind, walking with a cane, grieving the deaths of his mentor, mother and son.",
      "claim_ids": [
        "CLM-0008",
        "CLM-0009",
        "CLM-0012"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1972-10-24",
        "display": "October 24, 1972",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died of a heart attack at his home in Stamford, Connecticut, at 53.",
      "claim_ids": [
        "CLM-0013",
        "CLM-0010",
        "CLM-0004"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Jackie Robinson was born on January 31, 1919, in Cairo, Georgia, to a family of sharecroppers.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "context",
          "locator": "roster birth year 1919"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "On April 15, 1947, he played his first major league game for the Brooklyn Dodgers, ending more than sixty years of segregation in major league baseball.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors his identity and his long experience of public pressure in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "His retirement from baseball was announced in January 1957; he then worked in business and as a spokesman and fundraiser for civil rights causes, including the NAACP.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors his later working life in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "retirement announced January 22, 1957"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "business and NAACP work"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "He had diabetes and high blood pressure; his death is attributed to heart problems and complications of diabetes.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the modern diabetes, hypertension and cardiovascular risk. The type and treatment of his diabetes are not given in the sources consulted.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "diabetes, hypertension, and the effects of several heart attacks"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "both diabetes and high blood pressure"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "heart problems and diabetes complications"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "He was diagnosed with diabetes at about 37, around the time he retired from baseball, and at first kept it private; two of his brothers also had diabetes.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Anchors the long duration of diabetes and the family history. Other accounts give other years, and one source says he acknowledged it only a few years after retiring.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "diagnosed at age 37, about the time he retired; two of his brothers also had diabetes"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "context",
          "locator": "acknowledged diabetes a few years after his retirement"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "By 1969, at 50, he had nerve and artery damage in his legs.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Anchors the modern peripheral artery disease and neuropathy. Single source.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In 1970 he had two mild strokes.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Anchors the history of stroke in the modern record. Single source.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "He lost the sight of one eye and had limited vision in the other; by 1972 he had nearly lost his sight and needed a cane to walk.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the modern vision-threatening retinopathy. The sources do not date the loss of each eye.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "lost sight in one eye and experienced limited vision in the other"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "had lost most of his vision"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "His loss of vision was most likely caused by diabetic retinopathy; the sources attribute his near-blindness to diabetes and its complications without naming the eye disease.",
      "evidence_grade": "R",
      "certainty": "probable",
      "clinical_interpretation": "Retrospective interpretation. The grade of retinopathy, macular edema and the hemorrhage in the modern episode are synthetic.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "derived_from",
          "locator": "almost blind, with underlying diabetes and associated complications"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "derived_from"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "He had several heart attacks; one account counts three, the third of which was fatal. The dates of the earlier ones are not given.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern coronary artery disease. Because the earlier heart attacks are not dated, the modern episode records no prior heart attack.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "three heart attacks, the third of which was fatal"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "the effects of several heart attacks"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "His eldest son, Jackie Robinson Jr., was killed in an automobile accident on June 17, 1971, at 24.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the bereavement in the modern episode, which begins six weeks later. Circumstances beyond the accident are not used.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "June 17, 1971: killed in an automobile accident"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "died in an automobile accident in 1971"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0012",
      "statement": "In his last year he grieved the deaths of his mentor, his mother and his first son.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the modern episode; supports the weight of grief he carried.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0013",
      "statement": "He died of a heart attack at his home in Stamford, Connecticut, on October 24, 1972, at 53.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the modern episode. Anchors his home in Stamford and the cardiovascular teaching objective.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "context",
          "locator": "gives October 23"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Swaine R. Jackie Robinson (SABR BioProject)",
      "publisher": "Society for American Baseball Research",
      "url": "https://sabr.org/bioproj/person/jackie-robinson/",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Researched biography; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Assembly Concurrent Resolution No. 197, relative to Jackie Robinson Day (chaptered)",
      "publisher": "California State Legislature",
      "url": "https://www.leginfo.ca.gov/pub/15-16/bill/asm/ab_0151-0200/acr_197_bill_20160901_chaptered.htm",
      "source_type": "government",
      "published": "2016-09-01",
      "accessed": "2026-11-05",
      "rights_note": "Legislative resolution; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Teaching With Documents: Letter from Jackie Robinson to Roland L. Elliott, April 20, 1972",
      "publisher": "U.S. National Archives and Records Administration",
      "url": "https://www.archives.gov/education/lessons/jackie-robinson/letter-1972.html",
      "source_type": "government",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Archival teaching page; background facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation)",
      "publisher": "University of California",
      "url": "https://www.universityofcalifornia.edu/news/did-racism-kill-jackie-robinson",
      "source_type": "scholarly",
      "published": "2021-04-08",
      "accessed": "2026-11-05",
      "rights_note": "Article by University of California researchers; health facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Jackie Robinson Timeline 1950-1979",
      "publisher": "Los Angeles Dodgers (MLB.com)",
      "url": "https://www.mlb.com/dodgers/history/jackie-robinson/timeline-1950",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Team history timeline; used for his son's death date and his later work. Gives his death date as October 23."
    },
    {
      "source_id": "SRC-0006",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-05",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-07-27",
    "index_age": 52,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Sight-, heart-, limb- and kidney-protecting care for a 52-year-old Black man with long-standing type 2 diabetes who comes in with blurred vision six weeks after the death of his son. The episode covers urgent retina care for proliferative diabetic retinopathy with macular edema and a vitreous hemorrhage (dilated examination, OCT, intravitreal anti-VEGF injections and panretinal photocoagulation, as the AAO Preferred Practice Pattern describes); lowering glucose steadily rather than quickly, with the early worsening of retinopathy after rapid A1c falls and after semaglutide explained and a GLP-1 receptor agonist started only after the retina is stable; an SGLT2 inhibitor for heart and kidney protection; a high-intensity statin with ezetimibe; blood pressure and kidney care; coronary disease found through exertional chest tightness; the ankle-brachial index, foot examination and wound care for a neuropathic heel blister; low-vision services and diabetes tools he can use with poor sight; depression screening and grief support; and the equity of care for a Black man with diabetes complications, under the ADA Standards of Care 2026, the AAO Diabetic Retinopathy Preferred Practice Pattern 2025, the 2024 ACC/AHA PAD and 2023 chronic coronary disease guidelines, and the CMID monographs.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-07-27",
        "purpose": "Visit for blurred vision and new floaters, chest tightness on stairs, calf pain on walking and numb feet, in a man with long-standing diabetes six weeks after the death of his son"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-07-29",
        "purpose": "Review after the retina consultation and first eye injections: retinal diagnosis, glucose, blood pressure and kidney medicines"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-08-17",
        "purpose": "Same-day sick visit for a blister on the right heel, and review of the stress test result"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-08-26",
        "purpose": "Four weeks after the new medicines: potassium and creatinine, blood pressure, ankle-brachial index, feet, mood, and the second eye injections"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-09-21",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-10-26",
        "purpose": "Three-month review: A1c, urine albumin, lipids, eyes after laser treatment, heart, legs, grief, and a GLP-1 receptor agonist"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arranged",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "H53.8",
            "display": "Other visual disturbances",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic presenting finding, superseded by the retinal diagnosis two days later.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-07-29"
      },
      {
        "id": "PRB-002",
        "display": "Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arranged",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R07.89",
            "display": "Other chest pain",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic presenting finding, superseded by the coronary diagnosis after the stress test.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-08-17"
      },
      {
        "id": "PRB-003",
        "display": "Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.65",
            "display": "Type 2 diabetes mellitus with hyperglycemia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern episode linked to his documented diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-004",
        "display": "Proliferative diabetic retinopathy in both eyes with center-involving diabetic macular edema (central subfield 412 microns right, 468 left); best-corrected acuity 35 letters right and 56 letters left",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.3513",
            "display": "Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic retinal findings anchored to his documented loss of vision.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-07-29"
      },
      {
        "id": "PRB-005",
        "display": "Vitreous hemorrhage in the right eye from proliferative retinopathy; retina attached on ultrasound",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "H43.11",
            "display": "Vitreous hemorrhage, right eye",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic finding.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-07-29"
      },
      {
        "id": "PRB-006",
        "display": "Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I12.9",
            "display": "Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern episode linked to his documented high blood pressure.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-007",
        "display": "Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.22",
            "display": "Type 2 diabetes mellitus with diabetic chronic kidney disease",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic kidney findings.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-008",
        "display": "Chronic kidney disease G2 A2",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N18.2",
            "display": "Chronic kidney disease, stage 2 (mild)",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic kidney finding.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-009",
        "display": "Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulses",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.51",
            "display": "Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern episode linked to the documented artery damage in his legs.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-010",
        "display": "Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testing",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.42",
            "display": "Type 2 diabetes mellitus with diabetic polyneuropathy",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern episode linked to the documented nerve damage in his legs.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-011",
        "display": "History of two mild strokes a year ago, without lasting weakness",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z86.73",
            "display": "Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented strokes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-012",
        "display": "Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dL",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E78.5",
            "display": "Hyperlipidemia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic laboratory finding.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-013",
        "display": "Bereavement: his eldest son died in a car crash six weeks ago",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z63.4",
            "display": "Disappearance and death of family member",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic modern coding of a documented loss; grief is treated as grief, not as a disorder.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-014",
        "display": "Coronary artery disease with stable angina on climbing stairs: a small reversible inferior perfusion defect on regadenoson stress imaging, ejection fraction 56%; medical therapy chosen with cardiology",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I25.119",
            "display": "Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic coronary diagnosis anchored to his documented heart disease; no heart attack is recorded before the episode.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-08-17"
      },
      {
        "id": "PRB-015",
        "display": "Friction blister of the right heel from new shoes, unroofed, 2.5 by 2 cm, clean base, without infection, in a neuropathic foot with peripheral artery disease",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "S90.821A",
            "display": "Blister (nonthermal), right foot, initial encounter",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic intercurrent problem at an unscheduled visit; it does not echo a documented event.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-08-17",
        "abatement_date": "2026-09-21"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Metformin 1,000 mg oral tablet, one tablet twice daily with meals",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "861004",
            "display": "metformin hydrochloride 1000 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily with meals"
        },
        "start_date": "2025-03-03",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic long-standing diabetes medicine, continued.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "847230",
            "display": "3 ML insulin glargine 100 UNT/ML Pen Injector",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 30,
          "unit": "[IU]"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "At bedtime, by the gradual titration plan"
        },
        "start_date": "2025-03-03",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic basal insulin for long-standing diabetes, titrated slowly so that the A1c falls gradually.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Lisinopril 20 mg oral tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "314077",
            "display": "lisinopril 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2025-03-03",
        "end_date": "2026-07-29",
        "indication_problem_ids": [
          "PRB-006",
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ACE inhibitor for hypertension with albuminuria.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake)",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "259255",
            "display": "atorvastatin 80 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-07-27",
        "indication_problem_ids": [
          "PRB-011",
          "PRB-009"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic high-intensity statin after strokes and with peripheral artery disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Aspirin 81 mg delayed-release oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "308416",
            "display": "aspirin 81 MG Delayed Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2025-03-03",
        "indication_problem_ids": [
          "PRB-011",
          "PRB-009"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic antiplatelet therapy after strokes; continued, since aspirin does not raise the risk of bleeding into the eye in diabetic retinopathy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutes",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2180666",
            "display": "glucagon 3 MG Nasal Powder",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "nasal",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "As needed for severe low blood sugar"
        },
        "start_date": "2026-07-27",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic rescue glucagon for a man on insulin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-012",
        "display": "Metoprolol succinate extended-release 25 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "866427",
            "display": "24 HR metoprolol succinate 25 MG Extended Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-08-12",
        "indication_problem_ids": [
          "PRB-014"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic anti-anginal medicine started by cardiology after the stress test.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-013",
        "display": "Nitroglycerin 0.4 mg sublingual tablet, one under the tongue for chest pain, repeated every five minutes up to three; call 911 if pain is not better five minutes after the first",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198039",
            "display": "nitroglycerin 0.4 MG Sublingual Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "sublingual",
        "frequency": {
          "period": 5,
          "period_unit": "min",
          "text": "As needed for chest pain, up to three doses"
        },
        "start_date": "2026-08-12",
        "indication_problem_ids": [
          "PRB-014"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic as-needed nitroglycerin started by cardiology.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Lisinopril 40 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197884",
            "display": "lisinopril 40 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily, with sick-day rules"
        },
        "start_date": "2026-07-29",
        "indication_problem_ids": [
          "PRB-006",
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic increase to the highest ACE inhibitor dose for hypertension with albuminuria.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Empagliflozin 10 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating, and before surgery or a colonoscopy preparation",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1545658",
            "display": "empagliflozin 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily, with sick-day rules"
        },
        "start_date": "2026-07-29",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-007",
          "PRB-014"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic SGLT2 inhibitor for heart and kidney protection, with a modest glucose effect that does not threaten the retina.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-010",
        "display": "Ezetimibe 10 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "349556",
            "display": "ezetimibe 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-10-26",
        "indication_problem_ids": [
          "PRB-012",
          "PRB-014"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic addition for LDL 74 mg/dL above the goal below 55 on atorvastatin 80 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-011",
        "display": "Dulaglutide 0.75 mg/0.5 mL pen, one injection under the skin once a week; dose to rise to 1.5 mg after at least four weeks only if the retina remains stable",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1551295",
            "display": "0.5 ML dulaglutide 1.5 MG/ML Auto-Injector",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 0.75,
          "unit": "mg"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 1,
          "period_unit": "wk",
          "text": "Once a week, same day each week"
        },
        "start_date": "2026-10-26",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-014"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GLP-1 receptor agonist with cardiovascular benefit, started at the lowest dose once the retina specialist judged the proliferative disease stable.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 10.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; his first goal below 8%, then below 7%, lowered gradually"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic A1c; well above goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (random)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 248,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 139
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic random glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 1.12,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 79,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 90,
          "text": "90 or higher is normal; 60 to 89 is mildly decreased (G2)"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR (CKD-EPI 2021, without a race term); mildly decreased.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V1",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 86,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio; moderately increased, as on a test he reports from last year.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 226,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 40 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 142,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99,
          "text": "Goal below 55 mg/dL with atherosclerotic disease"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 40 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 38,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 40 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 230,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 40 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 28,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ALT, for FIB-4 and before the statin increase.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 48
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic AST, for FIB-4.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 13.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.5,
          "high": 17.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 250,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic platelets, for FIB-4.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V1",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 380,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin B12 on long-term metformin, with neuropathy; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 1.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-27",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic depression screen six weeks after his son's death: mild symptoms, item 9 scored 0. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAR-V2",
        "display": "Visual acuity best corrected Right eye by ETDRS eye chart",
        "label": "Best-corrected visual acuity, right eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-07-29",
        "value": 35,
        "unit": "{letters}",
        "reference_range": {
          "low": 80,
          "text": "85 letters is about 20/20; 35 letters is about 20/200"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79876-9",
            "display": "Visual acuity best corrected Right eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic best-corrected acuity at the retina clinic; about 20/200, limited by vitreous hemorrhage and macular edema.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAL-V2",
        "display": "Visual acuity best corrected Left eye by ETDRS eye chart",
        "label": "Best-corrected visual acuity, left eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-07-29",
        "value": 56,
        "unit": "{letters}",
        "reference_range": {
          "low": 80,
          "text": "85 letters is about 20/20; 55 letters is about 20/80"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79877-7",
            "display": "Visual acuity best corrected Left eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic best-corrected acuity at the retina clinic; about 20/80, limited by macular edema.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CSTR-V2",
        "display": "Macular grid.center subfield thickness by OCT",
        "label": "Central subfield thickness by OCT, right eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-07-29",
        "value": 412,
        "unit": "um",
        "reference_range": {
          "low": 200,
          "high": 300
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "57109-1",
            "display": "Macular grid.center subfield thickness by OCT",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic OCT central subfield thickness; center-involving macular edema.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CSTL-V2",
        "display": "Macular grid.center subfield thickness by OCT",
        "label": "Central subfield thickness by OCT, left eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-07-29",
        "value": 468,
        "unit": "um",
        "reference_range": {
          "low": 200,
          "high": 300
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "57109-1",
            "display": "Macular grid.center subfield thickness by OCT",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic OCT central subfield thickness; center-involving macular edema.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V5",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-21",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; below the threshold. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V5",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-09-21",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-26",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel four weeks after the lisinopril increase and empagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-26",
        "value": 4.8,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel four weeks after the lisinopril increase and empagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-26",
        "value": 1.22,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel four weeks after the lisinopril increase and empagliflozin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-26",
        "value": 71,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 90,
          "text": "90 or higher is normal; 60 to 89 is mildly decreased (G2)"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; a dip of about 10%, expected after these medicines.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ABIR-V4",
        "display": "Ankle-brachial index",
        "label": "Ankle-brachial index, right",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-26",
        "value": 0.68,
        "unit": "{ratio}",
        "reference_range": {
          "low": 1.0,
          "high": 1.4,
          "text": "1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormal"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "77194-9",
            "display": "Ankle-brachial index",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ankle-brachial index; moderate peripheral artery disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ABIL-V4",
        "display": "Ankle-brachial index",
        "label": "Ankle-brachial index, left",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-26",
        "value": 0.74,
        "unit": "{ratio}",
        "reference_range": {
          "low": 1.0,
          "high": 1.4,
          "text": "1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormal"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "77194-9",
            "display": "Ankle-brachial index",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ankle-brachial index; moderate peripheral artery disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V6",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 9.2,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; his first goal below 8%, then below 7%, lowered gradually"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c at three months; a gradual fall of 1.2 points.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V6",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 54,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio three months after the treatment changes; down 37%.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V6",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V6",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 4.7,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V6",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 1.18,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V6",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 74,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 90,
          "text": "90 or higher is normal; 60 to 89 is mildly decreased (G2)"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V6",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 150,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel thirteen weeks after the atorvastatin increase.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V6",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 74,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99,
          "text": "Goal below 55 mg/dL with atherosclerotic disease"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel thirteen weeks after the atorvastatin increase.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V6",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 40,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel thirteen weeks after the atorvastatin increase.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V6",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 180,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel thirteen weeks after the atorvastatin increase.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V6",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 30,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ALT on atorvastatin 80 mg; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V6",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-26",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic PHQ-9 at three months; mild symptoms, item 9 scored 0. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Twelve-lead electrocardiogram",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-07-27",
          "end": "2026-07-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic ECG for exertional chest tightness: sinus rhythm, nonspecific lateral T-wave flattening, no Q waves and no acute change (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Comprehensive diabetic foot examination with a 10-g monofilament, vibration and pulses",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "401191002",
            "display": "Diabetic foot examination",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-07-27",
          "end": "2026-07-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic foot examination; protective sensation absent in both forefeet, faint foot pulses, no ulcer (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Dilated fundus examination of both eyes with B-scan ultrasound of the right eye, at the retina clinic",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "36228007",
            "display": "Ophthalmic examination and evaluation",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-07-29",
          "end": "2026-07-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic retina examination: neovascularization of the disc and elsewhere in both eyes, vitreous hemorrhage on the right with the retina attached, and macular edema in both eyes (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Optical coherence tomography of the macula, both eyes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "700070005",
            "display": "Optical coherence tomography of retina",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-07-29",
          "end": "2026-07-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic OCT; center-involving macular edema in both eyes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Intravitreal injection of aflibercept 2 mg, both eyes (injection 1)",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1004045004",
            "display": "Intravitreal injection of anti-vascular endothelial growth factor",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-07-29",
          "end": "2026-07-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic first monthly anti-VEGF injections for macular edema and proliferative retinopathy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Regadenoson myocardial perfusion stress study, at the cardiology clinic",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "16545191000119100",
            "display": "Radionuclide myocardial perfusion stress study",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-08-12",
          "end": "2026-08-12"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic stress test: small reversible inferior defect, ejection fraction 56% (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Wound care of the right heel blister by the clinic nurse: cleansing, non-adherent dressing and a heel offloading shoe",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "225358003",
            "display": "Wound care",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-08-17",
          "end": "2026-08-17"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic wound care.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Intravitreal injection of aflibercept 2 mg, both eyes (injection 2), at the retina clinic",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1004045004",
            "display": "Intravitreal injection of anti-vascular endothelial growth factor",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-08-26",
          "end": "2026-08-26"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic second monthly injections.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-009",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-21",
          "end": "2026-09-21"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only his own general preferences in the modern episode.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-010",
        "display": "Optical coherence tomography of the macula, both eyes, at the retina clinic",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "700070005",
            "display": "Optical coherence tomography of retina",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-23",
          "end": "2026-09-23"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic OCT before the third injections: central subfield 318 microns right and 334 left (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-011",
        "display": "Intravitreal injection of aflibercept 2 mg, both eyes (injection 3), at the retina clinic",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1004045004",
            "display": "Intravitreal injection of anti-vascular endothelial growth factor",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-23",
          "end": "2026-09-23"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic third monthly injections.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-012",
        "display": "Panretinal photocoagulation, right eye (first session), at the retina clinic",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "413180006",
            "display": "Pan retinal photocoagulation for diabetes",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-10-07",
          "end": "2026-10-07"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic laser treatment once the vitreous hemorrhage had cleared enough to allow it.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, inactivated, this season",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose for an adult 50 or older with diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose; none on record.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "COVID-19 vaccine, mRNA, this season",
        "status": "completed",
        "date": "2026-10-26",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-10-26",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination for an adult with diabetes under 60.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "BRO",
          "display": "brother"
        },
        "condition": "Two of his brothers had diabetes",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "FH-002",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "SON",
          "display": "natural son"
        },
        "condition": "His eldest son died in an automobile accident at 24",
        "age_at_death": 24,
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Diabetes diagnosed at about 37, around his retirement from baseball",
        "historical_date": {
          "iso": "1957",
          "display": "about 1957",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Nerve and artery damage in both legs",
        "historical_date": {
          "iso": "1969",
          "display": "by 1969",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Two mild strokes",
        "historical_date": {
          "iso": "1970",
          "display": "1970",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Visit for blurred vision and new floaters, chest tightness on stairs, calf pain on walking and numb feet, in a man with long-standing diabetes six weeks after the death of his son",
        "status": "finished",
        "date": "2026-07-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Review after the retina consultation and first eye injections: retinal diagnosis, glucose, blood pressure and kidney medicines",
        "status": "finished",
        "date": "2026-07-29",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Review after the retina consultation and first eye injections: retinal diagnosis, glucose, blood pressure and kidney medicines",
          "hpi": {
            "narrative": "Mr. Robinson returns two days after his first visit, from the retina clinic this morning. Dr. Ostrowski-Lane examined both eyes with dilating drops, used ultrasound to confirm that the right retina is attached behind the blood, and measured the swelling at the center of each retina by OCT. She found proliferative diabetic retinopathy in both eyes with swelling of the macula in both, and bleeding into the gel of the right eye, and gave the first aflibercept injections in both eyes. His eyes are a little sore, as expected. He had no flashes or curtain over his vision. He asked how quickly his sugar should come down, because he wants it fixed at once, and what the injections will do. Chest tightness on stairs is unchanged; the stress test is booked.",
            "elements": [
              {
                "label": "Retina clinic",
                "value": "Proliferative retinopathy with macular edema in both eyes, right vitreous hemorrhage, retina attached; first injections given"
              },
              {
                "label": "Symptoms",
                "value": "Mild eye soreness; no flashes or curtain"
              },
              {
                "label": "Chest",
                "value": "Tightness on stairs unchanged; stress test booked"
              }
            ]
          },
          "ros": [
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Blurred vision; mild soreness after the injections; no flashes"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Chest tightness on stairs, easing with rest; calf pain after a block"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No low blood sugar"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Grieving; sleeps poorly"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 148/90, pulse 82; weight 103.8 kg"
            },
            {
              "system": "Eyes",
              "finding": "Mild redness at the injection sites; pupils dilated from the retina examination"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no ankle swelling"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Proliferative diabetic retinopathy with center-involving macular edema, both eyes",
              "assessment": "Vision-threatening disease in both eyes: best-corrected acuity 35 letters right and 56 left; central subfield 412 and 468 microns. Treatment has begun",
              "plan": [
                "Monthly aflibercept for three doses, then by response",
                "Laser to the right eye when the blood clears",
                "Low-vision evaluation booked",
                "Same-day return for a curtain over the vision, flashes or a sudden loss"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Type 2 diabetes",
              "assessment": "A1c 10.4%. A rapid fall in A1c can briefly worsen proliferative retinopathy, and semaglutide was linked to more retinopathy complications in a cardiovascular trial; the aim is a steady fall of about one point every three months, with the retina specialist watching monthly",
              "plan": [
                "Continue metformin and the slow glargine titration plan",
                "Empagliflozin 10 mg daily",
                "A GLP-1 receptor agonist to be considered once the retina specialist judges the retina stable",
                "Talking glucose meter and large-print plan"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "148/90, above the goal below 130/80, with albuminuria",
              "plan": [
                "Lisinopril increased to 40 mg",
                "Potassium and creatinine in four weeks"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Diabetic kidney disease with albuminuria",
              "assessment": "eGFR 79 with a urine albumin-to-creatinine ratio of 86 mg/g, raised also last year: G2 A2. An SGLT2 inhibitor and the highest ACE inhibitor dose protect kidneys and heart",
              "plan": [
                "Empagliflozin and lisinopril as above; written sick-day rules",
                "Urine albumin at three months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure (seated, two readings, large cuff)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "148/90",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "103.8 kg, BMI 32.0",
              "guideline_ids": [
                "GL-ADA-GLY-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Retina care: acuity, OCT, injections and laser",
              "cadence": "Monthly at the retina clinic while treating",
              "status": "completed_today",
              "detail": "Retina clinic today: acuity 35 letters right and 56 left; central subfield 412 and 468 microns; first injections both eyes",
              "observation_ids": [
                "OBS-VAR-V2",
                "OBS-VAL-V2",
                "OBS-CSTR-V2",
                "OBS-CSTL-V2"
              ],
              "guideline_ids": [
                "GL-AAO-DR-2025",
                "GL-ADA-RETFOOT-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c",
              "cadence": "Every 3 months while not at goal or after a change",
              "status": "up_to_date",
              "detail": "10.4% two days ago; next at three months",
              "guideline_ids": [
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Glucose log and low blood sugar review (talking meter)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Readings 170 to 260 mg/dL; no lows; talking meter ordered",
              "guideline_ids": [
                "GL-ADA-GLY-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine and eGFR",
              "cadence": "Two to four weeks after starting or increasing an ACE inhibitor or SGLT2 inhibitor; then every 6 to 12 months",
              "status": "ordered",
              "detail": "Lisinopril increased and empagliflozin started today; check in four weeks",
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Three to six months after a treatment change; then 1 to 4 times a year by risk",
              "status": "up_to_date",
              "detail": "86 mg/g two days ago, raised also last year; next at three months",
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after starting or changing a statin; then yearly",
              "status": "due",
              "detail": "Atorvastatin increased to 80 mg two days ago; due in 4 to 12 weeks",
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety: low blood sugar, sick-day rules, genital infection, dizziness, cost",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sick-day rules for empagliflozin and lisinopril written in large print; genital hygiene advice; glucagon shown",
              "guideline_ids": [
                "GL-ADA-PHARM-2026",
                "GL-ADA-CKD-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Retina consultation",
              "cadence": "Within 48 hours for new floaters and vision loss with diabetes",
              "status": "completed_today",
              "detail": "Seen by Dr. Ostrowski-Lane today",
              "guideline_ids": [
                "GL-AAO-DR-2025"
              ]
            }
          ],
          "follow_up": "Stress test as booked. Second injections and review in four weeks with potassium and creatinine and the ankle-brachial index. Call for a curtain over the vision, flashes, eye pain with redness, chest pain at rest, dizziness, or vomiting (hold empagliflozin and lisinopril that day)",
          "guideline_ids": [
            "GL-AAO-DR-2025",
            "GL-ADA-RETFOOT-2026",
            "GL-ADA-GLY-2026",
            "GL-ADA-PHARM-2026",
            "GL-ADA-CVD-2026",
            "GL-ADA-CKD-2026",
            "GL-KDIGO-CKD-2024",
            "GL-AHA-HTN-2025",
            "GL-SUSTAIN6-2016",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Same-day sick visit for a blister on the right heel",
        "status": "finished",
        "date": "2026-08-17",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "A blister on the right heel, found last night",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. Robinson asked for a same-day visit. Two days ago he wore new dress shoes for a long day of meetings and a dinner. Last night he found blood on his right sock; he had felt nothing, because his feet are numb, and could not see the heel well, so he used the magnifying mirror and bright lamp he was given and saw a broken blister. He has had no fever, chills, spreading redness or drainage. His glucose readings on the talking meter have run 150 to 210 mg/dL. Separately, he had the regadenoson stress test five days ago; the cardiologist found a small area of reduced blood flow at the bottom of the heart with normal pumping, started metoprolol and nitroglycerin to carry, and chose medical treatment. His chest tightness on stairs has been less since, and he has not needed the nitroglycerin. His vision is a little clearer since the first eye injections.",
            "elements": [
              {
                "label": "Onset",
                "value": "Found last night; new shoes worn two days ago"
              },
              {
                "label": "Location",
                "value": "Back of the right heel"
              },
              {
                "label": "Severity",
                "value": "Painless because of neuropathy"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "No fever, spreading redness or drainage"
              },
              {
                "label": "Context",
                "value": "Loss of protective sensation and peripheral artery disease; low vision limits foot checks"
              },
              {
                "label": "Heart",
                "value": "Stress test five days ago; metoprolol and nitroglycerin started by cardiology; chest tightness less"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or chills"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Blister on the right heel; no other skin breaks"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Chest tightness on stairs, less since metoprolol; calf pain after about a block"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No low blood sugar"
            },
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Vision still blurred, a little clearer"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; temperature 36.7 °C; blood pressure 136/84, pulse 64"
            },
            {
              "system": "Right foot",
              "finding": "Unroofed blister on the back of the heel, 2.5 by 2 cm, pink moist base, no slough, no surrounding redness, warmth, swelling or odor; does not probe to bone; dorsalis pedis and posterior tibial pulses faint; capillary refill slow"
            },
            {
              "system": "Left foot",
              "finding": "Intact skin; callus under the first metatarsal head; pulses faint"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-015",
              "display": "Friction blister of the right heel in a neuropathic foot with peripheral artery disease",
              "assessment": "Superficial and clean, without infection, so no antibiotic. With loss of sensation and reduced blood flow this is a high-risk wound that needs offloading and close review",
              "plan": [
                "Cleansed and dressed by the clinic nurse; non-adherent dressing changed daily",
                "Heel offloading shoe; no new shoes until fitted by podiatry",
                "Visiting nurse three times a week; large-print dressing guide",
                "Podiatry within two days",
                "Ankle-brachial index at the four-week visit in nine days",
                "Return the same day for redness, swelling, drainage, odor or fever"
              ]
            },
            {
              "problem_id": "PRB-014",
              "display": "Coronary artery disease with stable angina",
              "assessment": "Stress imaging with regadenoson, chosen because calf pain limits walking, showed a small reversible inferior defect with an ejection fraction of 56%. Symptoms are mild and improving on metoprolol; medical therapy is appropriate",
              "plan": [
                "Metoprolol succinate 25 mg daily and nitroglycerin as needed, as cardiology started",
                "Continue atorvastatin 80 mg and aspirin",
                "Call 911 for chest pain that lasts more than five minutes after nitroglycerin"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Type 2 diabetes",
              "assessment": "Readings 150 to 210 mg/dL; no low blood sugar. Healing needs steady glucose, but the gradual plan stands",
              "plan": [
                "Continue the glargine titration plan"
              ]
            }
          ],
          "follow_up": "Visiting nurse from tomorrow; podiatry within two days; review in nine days at the four-week visit with the ankle-brachial index"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-004",
        "display": "Four weeks after the new medicines: potassium and creatinine, blood pressure, ankle-brachial index, feet, mood, and the second eye injections",
        "status": "finished",
        "date": "2026-08-26",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Four weeks after the new medicines: potassium and creatinine, blood pressure, ankle-brachial index, feet, mood, and the second eye injections",
          "hpi": {
            "narrative": "Mr. Robinson returns four weeks after the lisinopril increase and empagliflozin, from his second eye injections this morning. Dr. Ostrowski-Lane reports the blood in the right eye is thinning and the macular swelling is less in both eyes. His heel blister is smaller with the dressings and the offloading shoe, and the podiatrist has seen him twice. Chest tightness is less since cardiology started metoprolol, and he has not used nitroglycerin. He has had no dizziness, genital itching or low blood sugar; fasting readings are 140 to 180 mg/dL. He has met the health center's grief counselor once and plans to continue.",
            "elements": [
              {
                "label": "Eyes",
                "value": "Second injections today; hemorrhage thinning; less swelling"
              },
              {
                "label": "Heel",
                "value": "Smaller; podiatry twice"
              },
              {
                "label": "Chest",
                "value": "Less tightness on metoprolol"
              },
              {
                "label": "Glucose",
                "value": "Fasting 140 to 180 mg/dL; no lows"
              }
            ]
          },
          "ros": [
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Vision a little clearer"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Calf pain after about a block; chest tightness less"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No burning or genital itching"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Heel wound healing"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Grieving; meeting a counselor"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 134/80, pulse 60; weight 102.8 kg"
            },
            {
              "system": "Right foot",
              "finding": "Heel wound 1.2 by 1 cm, clean granulating base, no infection"
            },
            {
              "system": "Feet",
              "finding": "Monofilament absent in both forefeet, as at intake; pulses faint"
            },
            {
              "system": "Vascular",
              "finding": "Ankle-brachial index 0.68 right and 0.74 left"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-007",
              "display": "Diabetic kidney disease with albuminuria",
              "assessment": "Potassium 4.8 mmol/L; creatinine 1.22 mg/dL, eGFR 71 from 79: a fall of about 10%, the expected effect of empagliflozin and the higher lisinopril dose",
              "plan": [
                "Continue both",
                "Urine albumin and kidney function at three months"
              ]
            },
            {
              "problem_id": "PRB-009",
              "display": "Peripheral artery disease",
              "assessment": "Ankle-brachial index 0.68 and 0.74: moderate disease in both legs, with claudication at one block. The heel wound is healing, so no vascular procedure is needed now",
              "plan": [
                "Supervised exercise therapy three times a week once the heel has healed",
                "Continue statin, aspirin and podiatry"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "134/80, nearly at goal on lisinopril 40 mg and metoprolol",
              "plan": [
                "No change"
              ]
            },
            {
              "problem_id": "PRB-013",
              "display": "Bereavement",
              "assessment": "Grieving; counseling started; no thoughts of self-harm",
              "plan": [
                "Continue counseling; PHQ-9 at three months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure (seated, two readings, large cuff)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "134/80",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "102.8 kg",
              "guideline_ids": [
                "GL-ADA-GLY-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine and eGFR",
              "cadence": "Two to four weeks after starting or increasing an ACE inhibitor or SGLT2 inhibitor; then every 6 to 12 months",
              "status": "completed_today",
              "detail": "Four weeks after the changes: sodium 138, potassium 4.8 mmol/L; creatinine 1.22 mg/dL; eGFR 71",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-K-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4"
              ],
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Ankle-brachial index",
              "cadence": "At diagnosis of peripheral artery disease; then with any change in symptoms or a wound",
              "status": "completed_today",
              "detail": "0.68 right and 0.74 left",
              "observation_ids": [
                "OBS-ABIR-V4",
                "OBS-ABIL-V4"
              ],
              "guideline_ids": [
                "GL-ACC-PAD-2024",
                "GL-ADA-RETFOOT-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Foot inspection; comprehensive foot examination",
              "cadence": "Every visit with loss of sensation; comprehensive examination yearly",
              "status": "completed_today",
              "detail": "Heel wound healing; no new breaks; sensation absent as before",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-IWGDF-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Retina care: acuity, OCT, injections and laser",
              "cadence": "Monthly at the retina clinic while treating",
              "status": "completed_today",
              "detail": "Second injections today; hemorrhage thinning; less swelling (retina clinic report)",
              "guideline_ids": [
                "GL-AAO-DR-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c",
              "cadence": "Every 3 months while not at goal or after a change",
              "status": "up_to_date",
              "detail": "Next at three months",
              "guideline_ids": [
                "GL-ADA-GLY-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Glucose log and low blood sugar review (talking meter)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Fasting 140 to 180 mg/dL on the talking meter; no lows",
              "guideline_ids": [
                "GL-ADA-GLY-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after starting or changing a statin; then yearly",
              "status": "due",
              "detail": "Due by twelve weeks after the atorvastatin increase",
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Angina review",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Less tightness on metoprolol; no nitroglycerin used",
              "guideline_ids": [
                "GL-AHA-CCD-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety: low blood sugar, sick-day rules, genital infection, dizziness, cost",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No low blood sugar, dizziness or genital infection",
              "guideline_ids": [
                "GL-ADA-PHARM-2026",
                "GL-ADA-CKD-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Low-vision services and diabetes tools he can use",
              "cadence": "When vision limits daily life",
              "status": "completed_today",
              "detail": "Low-vision evaluation booked; talking meter in use; large-print plans",
              "guideline_ids": [
                "GL-AAO-DR-2025",
                "GL-ADA-RETFOOT-2026"
              ]
            }
          ],
          "follow_up": "Preventive visit in four weeks. Third injections in four weeks and laser to the right eye when the blood clears. Three-month review in two months with the A1c, urine albumin, lipids and kidney function",
          "guideline_ids": [
            "GL-ADA-CKD-2026",
            "GL-KDIGO-CKD-2024",
            "GL-ACC-PAD-2024",
            "GL-ADA-RETFOOT-2026",
            "GL-IWGDF-2023",
            "GL-AAO-DR-2025",
            "GL-ADA-GLY-2026",
            "GL-ADA-PHARM-2026",
            "GL-ADA-CVD-2026",
            "GL-AHA-CCD-2023",
            "GL-AHA-HTN-2025",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-09-21",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Read aloud and completed with the nurse before the visit, because he cannot read print, and reviewed with him by Dr. Delacroix-Hale",
          "hpi": {
            "narrative": "Mr. Robinson comes for his yearly preventive visit, nearly four weeks after his four-week review. The heel blister has healed under the podiatrist's care and he wears the fitted shoes. He has had the third eye injections booked for this week. He walks a little farther in the supervised exercise program. He has had no chest pain since metoprolol and no low blood sugar. He says he is still carrying his son's death, that the grief counselor has helped, and that he sleeps better. He asked which screening tests he needs.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 52"
              },
              {
                "label": "Heel",
                "value": "Healed"
              },
              {
                "label": "Mood",
                "value": "PHQ-2 2; meeting the grief counselor"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair"
            },
            {
              "domain": "Psychosocial",
              "finding": "Grieving his son; supported at home and by his faith; meeting a grief counselor; keeps working"
            },
            {
              "domain": "Substance use",
              "finding": "No tobacco, alcohol or drug use"
            },
            {
              "domain": "Physical activity",
              "finding": "Supervised walking program three times a week"
            },
            {
              "domain": "Nutrition",
              "finding": "Working with the dietitian on smaller portions and fewer refined starches"
            },
            {
              "domain": "Sleep",
              "finding": "Six hours, better than in the summer"
            },
            {
              "domain": "Vision and safety",
              "finding": "Cannot read print or drive; uses voice tools on his phone; no falls"
            },
            {
              "domain": "Home safety",
              "finding": "Smoke detectors; better lighting on the stairs since the low-vision visit"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent; needs help with print and driving"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; weight down 1.8 kg since intake"
            },
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Vision still reduced, clearer than in the summer"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing change; no gum bleeding"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Calf pain after about two blocks; no chest pain"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No blood in the stool or change in bowel habit"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No difficulty passing urine; no genital itching"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "Knees stiff in the morning; no swelling"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "Heel healed; no new skin breaks"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Numb feet, unchanged; no new weakness"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Grief; sleeping better; PHQ-2 2"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 102.2 kg; blood pressure 128/78, pulse 62"
            },
            {
              "system": "Eyes",
              "finding": "Counting the large letters at the top of the chart with the right eye and 20/60 with the left"
            },
            {
              "system": "Mouth",
              "finding": "Gums healthy"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; no aortic bruit"
            },
            {
              "system": "Feet",
              "finding": "Right heel healed with intact skin; fitted shoes; pulses faint"
            },
            {
              "system": "Skin",
              "finding": "No suspicious lesions"
            },
            {
              "system": "Psychiatric",
              "finding": "Composed; sad when speaking of his son; no thoughts of self-harm"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated, in large print and read aloud. Colorectal and prostate screening discussed: he chose a colonoscopy, with written instructions for holding metformin, empagliflozin and part of the insulin dose during the bowel preparation; after discussion of the higher risk of prostate cancer in Black men and of the harms of screening, he chose a PSA test. HIV and hepatitis C screening sent with his agreement",
              "plan": [
                "Colonoscopy in the next two months, after the eye laser",
                "PSA, HIV and hepatitis C results at the next visit",
                "COVID-19 and hepatitis B vaccines at the next visit; zoster dose 2 in two to six months",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-015",
              "display": "Right heel blister",
              "assessment": "Healed in five weeks with offloading and podiatry care",
              "plan": [
                "Podiatry every two to three months; inspect feet daily with the mirror and lamp, or with the visiting nurse"
              ]
            },
            {
              "problem_id": "PRB-013",
              "display": "Bereavement",
              "assessment": "Grieving, as expected three months after his son's death; PHQ-2 2; counseling helping",
              "plan": [
                "Continue meeting the grief counselor",
                "PHQ-9 at the three-month review"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure",
              "status": "completed_today",
              "detail": "128/78 mmHg",
              "guideline_ids": [
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 2; grief support in place",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 0",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "Colonoscopy, his choice, with diabetes medicine instructions for the preparation",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "ordered",
              "detail": "PSA after shared decision-making, including the higher risk in Black men",
              "guideline_ids": [
                "GL-USPSTF-PROSTATE-2018"
              ]
            },
            {
              "service": "HIV screening",
              "status": "completed_today",
              "detail": "Once for adults 15 to 65; sent with his agreement",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "completed_today",
              "detail": "Once for adults 18 to 79; sent with his agreement",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Influenza vaccine, this season",
              "status": "completed_today",
              "detail": "Given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20 today; no further doses",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "completed_today",
              "detail": "Dose 1 today; dose 2 in two to six months",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine and hepatitis B vaccine",
              "status": "due",
              "detail": "At the next visit, to space the injections; hepatitis B for adults with diabetes under 60",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus booster",
              "status": "up_to_date",
              "detail": "Tdap five years ago"
            },
            {
              "service": "Diabetic eye examination",
              "status": "up_to_date",
              "detail": "Under monthly retina care",
              "guideline_ids": [
                "GL-AAO-DR-2025"
              ]
            },
            {
              "service": "Comprehensive foot examination",
              "status": "up_to_date",
              "detail": "At intake; podiatry care ongoing",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026"
              ]
            },
            {
              "service": "Dental examination",
              "status": "due",
              "detail": "Yearly; not seen this year",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoker"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment for any illness that can be reversed, including heart procedures if they become necessary, and wants plain information about his eyes, heart and legs so that he can decide for himself. He has named a health care agent, recorded in the confidential part of the chart and not named here, and chose not to record other treatment preferences today. To be revisited yearly or after any serious illness.",
          "follow_up": "Third eye injections this week and laser to the right eye in two weeks at the retina clinic. Colonoscopy as arranged. Three-month review in five weeks with the A1c, urine albumin, lipids, kidney function, PHQ-9 and screening results. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-PROSTATE-2018",
            "GL-USPSTF-HIV-2019",
            "GL-USPSTF-HCV-2020",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-DEP-2023"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-006",
        "display": "Three-month review: A1c, urine albumin, lipids, eyes after laser treatment, heart, legs, grief, and a GLP-1 receptor agonist",
        "status": "finished",
        "date": "2026-10-26",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Three-month review: A1c, urine albumin, lipids, eyes after laser treatment, heart, legs, grief, and a GLP-1 receptor agonist",
          "hpi": {
            "narrative": "Mr. Robinson returns three months after his first visit. He had the third injections in both eyes a month ago and laser treatment to the right eye nearly three weeks ago. Dr. Ostrowski-Lane reports that the blood has largely cleared, the new vessels are regressing, the macular swelling is much less (central subfield 318 microns right and 334 left at the last scan), and his acuity has improved to 52 letters right and 68 left; she judges the retina stable enough to start a GLP-1 receptor agonist at a low dose with monthly review. The low-vision visit gave him magnifiers and better lighting. He walks two and a half blocks before calf pain in the exercise program. No chest pain. No low blood sugar. His PSA, HIV and hepatitis C tests were normal. He says the counseling helps and he sleeps better, though the loss is with him every day.",
            "elements": [
              {
                "label": "Eyes",
                "value": "Three injections both eyes and laser right eye; acuity 52 and 68 letters"
              },
              {
                "label": "Walking",
                "value": "Two and a half blocks"
              },
              {
                "label": "Screening",
                "value": "PSA, HIV and hepatitis C normal"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 6"
              }
            ]
          },
          "ros": [
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Vision clearer; reads large print with a magnifier"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Calf pain after two and a half blocks; no chest pain"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No low blood sugar"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea or change in bowel habit"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Grieving; sleeping better"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 126/76, pulse 60; weight 101.4 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no ankle swelling"
            },
            {
              "system": "Feet",
              "finding": "Heel healed; no new breaks; fitted shoes"
            },
            {
              "system": "Psychiatric",
              "finding": "Composed; no thoughts of self-harm"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Type 2 diabetes",
              "assessment": "A1c 9.2% from 10.4%: the steady fall planned, without low blood sugar. With the retina stable, a GLP-1 receptor agonist adds cardiovascular protection and glucose lowering",
              "plan": [
                "Dulaglutide 0.75 mg weekly, rising to 1.5 mg after four weeks only if the retina stays stable at the monthly review",
                "Reduce glargine by 4 units if fasting readings fall below 100 mg/dL",
                "A1c in three months"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Proliferative diabetic retinopathy with macular edema",
              "assessment": "Responding: hemorrhage largely cleared, new vessels regressing, macular swelling much less",
              "plan": [
                "Retina clinic monthly, with injections extended as the swelling allows and laser to the left eye if new vessels persist"
              ]
            },
            {
              "problem_id": "PRB-012",
              "display": "Hyperlipidemia",
              "assessment": "LDL 74 mg/dL from 142 on atorvastatin 80 mg: better, still above the goal below 55 with his stroke, coronary and leg artery disease. ALT 30 U/L",
              "plan": [
                "Add ezetimibe 10 mg",
                "Lipids in four to eight weeks, booked today"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Diabetic kidney disease with albuminuria",
              "assessment": "Urine albumin-to-creatinine ratio 54 mg/g from 86, a fall of 37%; potassium 4.7 mmol/L; creatinine 1.18 mg/dL, eGFR 74",
              "plan": [
                "Continue lisinopril 40 mg and empagliflozin",
                "Urine albumin and kidney function in six months"
              ]
            },
            {
              "problem_id": "PRB-013",
              "display": "Bereavement",
              "assessment": "PHQ-9 6 from 9; grief continuing, with support",
              "plan": [
                "Continue counseling; PHQ-9 again in six months or sooner if he wishes"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure (seated, two readings, large cuff)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "126/76",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "101.4 kg, down 2.6 kg",
              "guideline_ids": [
                "GL-ADA-GLY-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c",
              "cadence": "Every 3 months while not at goal or after a change",
              "status": "completed_today",
              "detail": "9.2%, from 10.4%",
              "observation_ids": [
                "OBS-A1C-V6"
              ],
              "guideline_ids": [
                "GL-ADA-GLY-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Three to six months after a treatment change; then 1 to 4 times a year by risk",
              "status": "completed_today",
              "detail": "54 mg/g, from 86",
              "observation_ids": [
                "OBS-UACR-V6"
              ],
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine and eGFR",
              "cadence": "Two to four weeks after starting or increasing an ACE inhibitor or SGLT2 inhibitor; then every 6 to 12 months",
              "status": "completed_today",
              "detail": "Sodium 139, potassium 4.7 mmol/L; creatinine 1.18 mg/dL; eGFR 74",
              "observation_ids": [
                "OBS-NA-V6",
                "OBS-K-V6",
                "OBS-CR-V6",
                "OBS-EGFR-V6"
              ],
              "guideline_ids": [
                "GL-ADA-CKD-2026",
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after starting or changing a statin; then yearly",
              "status": "deferred",
              "detail": "Late: the panel due 4 to 12 weeks after the atorvastatin increase was not ordered at the four-week visit and was drawn today, at thirteen weeks. No harm: LDL 74 mg/dL, total cholesterol 150, HDL 40, triglycerides 180 mg/dL; ALT 30 U/L. Corrective action: follow-up lipids for today's ezetimibe booked before he left, at four to eight weeks",
              "observation_ids": [
                "OBS-CHOL-V6",
                "OBS-LDL-V6",
                "OBS-HDL-V6",
                "OBS-TG-V6",
                "OBS-ALT-V6"
              ],
              "guideline_ids": [
                "GL-ADA-CVD-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Retina care: acuity, OCT, injections and laser",
              "cadence": "Monthly at the retina clinic while treating",
              "status": "completed_today",
              "detail": "Retina report reviewed: third injections and right-eye laser done; central subfield 318 and 334 microns; acuity 52 and 68 letters; monthly review continues",
              "guideline_ids": [
                "GL-AAO-DR-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Retinopathy safety with a GLP-1 receptor agonist",
              "cadence": "Retina review within a month of starting and before each dose increase",
              "status": "completed_today",
              "detail": "Started only with the retina specialist's agreement; lowest dose; monthly review booked",
              "guideline_ids": [
                "GL-SUSTAIN6-2016",
                "GL-AAO-DR-2025",
                "GL-ADA-RETFOOT-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Ankle-brachial index",
              "cadence": "At diagnosis of peripheral artery disease; then with any change in symptoms or a wound",
              "status": "not_indicated",
              "detail": "No change in symptoms and no wound; repeat only if symptoms change",
              "guideline_ids": [
                "GL-ACC-PAD-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Foot inspection; comprehensive foot examination",
              "cadence": "Every visit with loss of sensation; comprehensive examination yearly",
              "status": "completed_today",
              "detail": "Heel healed; no new breaks",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-IWGDF-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Angina review",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No angina on metoprolol",
              "guideline_ids": [
                "GL-AHA-CCD-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At intake and at three months while grieving; at least yearly",
              "status": "completed_today",
              "detail": "PHQ-9 6, item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V6"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-ADA-BEH-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Vitamin B12 on metformin",
              "cadence": "Periodically on long-term metformin",
              "status": "up_to_date",
              "detail": "380 pg/mL at intake",
              "guideline_ids": [
                "GL-ADA-PHARM-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety: low blood sugar, sick-day rules, genital infection, dizziness, cost",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No low blood sugar; sick-day rules reviewed for the colonoscopy preparation",
              "guideline_ids": [
                "GL-ADA-PHARM-2026",
                "GL-ADA-CKD-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "COVID-19 and hepatitis B vaccines",
              "cadence": "COVID-19 each autumn; hepatitis B for adults with diabetes under 60",
              "status": "completed_today",
              "detail": "Both given; hepatitis B dose 2 in one month; zoster dose 2 due",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Low-vision services and diabetes tools he can use",
              "cadence": "When vision limits daily life",
              "status": "completed_today",
              "detail": "Low-vision evaluation done: magnifiers, lighting and voice tools",
              "guideline_ids": [
                "GL-AAO-DR-2025"
              ]
            }
          ],
          "follow_up": "Retina clinic monthly. Lipids in four to eight weeks. Hepatitis B dose 2 in one month. Colonoscopy next month with the written preparation plan. Review in three months with the A1c. Call for nausea or vomiting that stops him drinking, any change in vision, chest pain, or a skin break on the feet",
          "guideline_ids": [
            "GL-ADA-GLY-2026",
            "GL-ADA-PHARM-2026",
            "GL-ADA-CVD-2026",
            "GL-ADA-CKD-2026",
            "GL-ADA-RETFOOT-2026",
            "GL-ADA-BEH-2026",
            "GL-AAO-DR-2025",
            "GL-SUSTAIN6-2016",
            "GL-ACC-PAD-2024",
            "GL-AHA-CCD-2023",
            "GL-AHA-HTN-2025",
            "GL-KDIGO-CKD-2024",
            "GL-USPSTF-DEP-2023",
            "GL-CDC-IMZ-2026",
            "GL-IWGDF-2023",
            "GL-CMID-2026"
          ]
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-07-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 104.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 32.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 152,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 92,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a large adult cuff. No measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-07-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 103.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 32.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 148,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 90,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a large adult cuff. No measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-08-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 103.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 136,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-08-26",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 102.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 60,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a large adult cuff. No measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-09-21",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 102.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 62,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-10-26",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 101.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 60,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a large adult cuff. No measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Lives in Stamford, Connecticut, with his wife; works in business and in civil rights causes in the region; a former major league ballplayer who broke the color line",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003",
            "CLM-0013"
          ],
          "synthetic_reason": "Synthetic modern social history anchored to his documented life; his wife is mentioned only as part of the household.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "His eldest son died in a car crash six weeks ago; he says he is carrying it, keeps working, and does not sleep well",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic statement in the modern episode, anchored to the documented death of his son.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Tobacco: never. Alcohol: none. No drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic entry for the modern episode; his real habits were not researched and are not used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Employer health insurance; medicines affordable with copay assistance for the newer ones",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic insurance status.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Strengths: discipline, a long habit of facing pressure in public, his faith, his work for civil rights, and a household that supports him",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic strengths anchored to his documented public life; no person is named or given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in daily activities; cannot read print or drive safely with his present vision; walks about one block before calf pain stops him",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic functional status anchored to his documented vision and leg problems.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, direct and composed; grief evident when speaking of his son; no thoughts of self-harm; PHQ-9 score 9",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Blurred vision in both eyes for two months and new floaters in the right eye for four days in a 52-year-old man with type 2 diabetes for about fifteen years and an A1c of 10.4%. Snellen acuity 20/200 right and 20/80 left; the undilated view of the right fundus is poor. Please examine for proliferative retinopathy, vitreous hemorrhage, retinal detachment and macular edema, and treat as needed",
        "urgency": "Within 48 hours, by phone arrangement today; same-day attendance if a curtain over the vision or flashes appear",
        "pertinent_history": "Mr. Robinson has had type 2 diabetes for about fifteen years, treated with metformin 1,000 mg twice daily and insulin glargine 30 units at bedtime; A1c today 10.4%, random glucose 248 mg/dL. He has hypertension (152/92 today on lisinopril 20 mg), albuminuria (urine albumin-to-creatinine ratio 86 mg/g, eGFR 79), peripheral artery disease with claudication at one block, loss of protective sensation in both feet, and two mild strokes a year ago without lasting weakness; he takes aspirin 81 mg, and atorvastatin was increased today to 80 mg (LDL 142 mg/dL). He reports chest tightness on stairs; a cardiology evaluation with a stress test is being arranged. He has not had a dilated eye examination for more than two years. His eldest son died six weeks ago, and he is grieving. He cannot read print or drive safely now and is afraid of losing his sight. He asks whether he must stop aspirin",
        "questions": [
          "What is the stage of retinopathy in each eye, is there macular edema, and is the right retina attached behind any hemorrhage?",
          "What treatment do you advise now (anti-VEGF injections, panretinal photocoagulation, vitrectomy), and on what schedule?",
          "How quickly should we lower his A1c, and should a GLP-1 receptor agonist such as semaglutide wait until the retina is stable?",
          "Should he continue aspirin with a vitreous hemorrhage?",
          "What can be done now for his daily vision, including reading, driving and managing insulin?",
          "How often will he need retina visits, and what should bring him back at once?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Robinson, 52, is seen at the request of Dr. Delacroix-Hale two days after he reported two months of blurred vision in both eyes and new floaters in the right eye. He has had no flashes, no curtain over his vision and no eye pain. He has had diabetes for about fifteen years, with high blood pressure, peripheral artery disease and two mild strokes a year ago, and his last dilated eye examination was more than two years ago. He takes aspirin. He is grieving the recent death of his son and is frightened of losing his sight. He agreed to examination with dilating drops, ultrasound and OCT, and, after the risks of infection, raised eye pressure and bleeding were explained, to injections today",
        "data_reviewed": "Dr. Delacroix-Hale's note and results: A1c 10.4%; blood pressure 152/92; eGFR 79; urine albumin-to-creatinine ratio 86 mg/g; LDL 142 mg/dL. Today: best-corrected acuity 35 letters right and 56 letters left (about 20/200 and 20/80). Intraocular pressure 16 mmHg right and 15 left. OCT: center-involving macular edema, central subfield 412 microns right and 468 left, with intraretinal fluid in both eyes. B-scan ultrasound of the right eye: vitreous hemorrhage, retina attached, no tractional detachment",
        "exam": [
          {
            "system": "Visual acuity",
            "finding": "Best-corrected 35 letters right and 56 letters left"
          },
          {
            "system": "Anterior segment",
            "finding": "Clear corneas; mild early lens opacity in both eyes; no new vessels on the iris or in the angle on gonioscopy"
          },
          {
            "system": "Right fundus (dilated)",
            "finding": "Dense inferior vitreous hemorrhage; neovascularization of the disc seen superiorly; macular thickening with exudates where visible"
          },
          {
            "system": "Left fundus (dilated)",
            "finding": "Neovascularization of the disc and elsewhere; intraretinal hemorrhages in four quadrants; hard exudates and thickening at the center of the macula"
          },
          {
            "system": "Vital signs",
            "finding": "Blood pressure 148/90 and pulse 82, measured today"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-004",
            "display": "Proliferative diabetic retinopathy with center-involving diabetic macular edema, both eyes",
            "assessment": "High-risk proliferative retinopathy in both eyes with center-involving macular edema and reduced vision in both. Anti-VEGF injections treat both the edema and the new vessels and are the first treatment; panretinal photocoagulation adds durable control of the proliferative disease and lessens the burden of frequent injections, and is done when the view allows"
          },
          {
            "problem_id": "PRB-005",
            "display": "Vitreous hemorrhage, right eye",
            "assessment": "From the new vessels; the retina is attached and there is no traction, so vitrectomy is not needed now. Most such hemorrhages clear over weeks with anti-VEGF treatment"
          },
          {
            "problem_id": "PRB-003",
            "display": "Type 2 diabetes",
            "assessment": "Better glucose control will protect his eyes over years, but a very rapid fall in A1c can worsen proliferative retinopathy for a time, and semaglutide was associated with more retinopathy complications in a cardiovascular outcomes trial, mainly in people with existing retinopathy and large early A1c falls. A steady fall of about one point every three months is reasonable, and a GLP-1 receptor agonist can be started once the proliferative disease is controlled, with monthly retina review. An SGLT2 inhibitor raises no retinal concern"
          }
        ],
        "recommendations": [
          "Aflibercept 2 mg in both eyes today and monthly for three doses, then treat-and-extend by OCT and examination",
          "Panretinal photocoagulation to the right eye once the hemorrhage clears enough to allow it, and to the left eye if new vessels persist after the first injections",
          "Vitrectomy if the right hemorrhage does not clear within one to three months, or if a retinal detachment develops",
          "Continue aspirin 81 mg: it does not increase the risk or severity of vitreous hemorrhage in diabetic retinopathy, and he needs it after his strokes",
          "Lower the A1c gradually, about one point every three months; delay a GLP-1 receptor agonist until I judge the retina stable, then start at the lowest dose with monthly retina review; an SGLT2 inhibitor and blood pressure and lipid treatment can go ahead now",
          "Low-vision evaluation now (magnifiers, lighting, phone and computer voice tools), a talking glucose meter and an insulin pen with audible clicks; he should not drive until acuity is reassessed",
          "Return the same day for a curtain over the vision, a sudden fall in vision, flashes, or a painful red eye after an injection"
        ],
        "communication": "Discussed with Dr. Delacroix-Hale by phone the same day. Mr. Robinson was shown his OCT images and told what the injections and laser can and cannot do; he asked many questions and chose to begin today",
        "follow_up": "Retina clinic in four weeks for the second injections, then monthly while treating. I will advise Dr. Delacroix-Hale when the retina is stable enough to start a GLP-1 receptor agonist"
      },
      "guideline_ids": [
        "GL-AAO-DR-2025",
        "GL-ADA-RETFOOT-2026",
        "GL-ADA-GLY-2026",
        "GL-SUSTAIN6-2016",
        "GL-AHA-STROKE-2021"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He is afraid of losing his sight and his independence",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He wants to keep working and to stay strong for his family after his son's death",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Vision kept or improved: proliferative disease regressed and macular edema reduced on anti-VEGF injections and laser",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "Hemorrhage clearing, new vessels regressing after three injections and laser to the right eye; macular thickness down in both eyes; acuity improved",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eye goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "A1c falling by about one point every three months without low blood sugar, to below 8% within six months and then below 7%",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "10.4% to 9.2% at three months; no low blood sugar",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diabetes goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Blood pressure below 130/80 mmHg",
        "status": "completed",
        "target_date": "2026-10-26",
        "outcome": "126/76 in the clinic",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "LDL cholesterol below 55 mg/dL",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "142 to 74 mg/dL on atorvastatin 80 mg; ezetimibe added",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Walk at least three blocks without stopping, through supervised exercise",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "From one block to two and a half blocks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic leg goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Feet kept intact: daily foot checks he can do with low vision, protective footwear, and prompt care for any skin break",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "A heel blister found early, healed in five weeks; footwear provided",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic foot goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-007",
        "display": "Grief acknowledged and supported, with depression screening repeated",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "Meeting the health center's grief counselor; PHQ-9 9 to 6",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic psychosocial goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Urgent retina consultation within 48 hours for blurred vision with new floaters in a man with long-standing diabetes: dilated examination, OCT, and treatment of any proliferative retinopathy or macular edema; same-day attendance for a curtain over the vision or flashes",
        "status": "completed",
        "guideline_ids": [
          "GL-AAO-DR-2025",
          "GL-ADA-RETFOOT-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic urgent specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Glucose: continue metformin and basal insulin, titrated slowly by a written plan so that the A1c falls gradually; rescue glucagon; diabetes self-management education adapted for low vision (a talking glucose meter, an insulin pen with audible dose clicks, large-print plans)",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-GLY-2026",
          "GL-ADA-PHARM-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic diabetes plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Cardiovascular risk: atorvastatin increased to 80 mg, aspirin continued, baseline ECG; cardiology evaluation of exertional chest tightness with a pharmacologic stress test, since calf pain limits walking",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CVD-2026",
          "GL-AHA-CCD-2023",
          "GL-AHA-STROKE-2021",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic cardiovascular plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Legs and feet: comprehensive foot examination today; ankle-brachial index; daily foot checks with a magnifying mirror and a bright lamp, protective shoes; podiatry",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-RETFOOT-2026",
          "GL-ACC-PAD-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic foot and leg plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Kidneys: repeat urine albumin and kidney function after any change in kidney medicines; no NSAIDs",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CKD-2026",
          "GL-KDIGO-CKD-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Grief and mood: acknowledge the loss, PHQ-9 now and at three months, and an offer of the health center's grief counselor, which he accepted; call or text 988 if thoughts of self-harm ever arise",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023",
          "GL-ADA-BEH-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Coronary disease, with cardiology: metoprolol succinate 25 mg daily and nitroglycerin as needed; continue high-intensity statin and aspirin; no revascularization now for a small area of ischemia with stable symptoms; review with cardiology in three months or sooner for worse or more frequent chest pain",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-CCD-2023",
          "GL-ADA-CVD-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic coronary plan reviewed at the first visit after the stress test.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-08-17"
      },
      {
        "id": "INT-008",
        "display": "Heel blister: daily dressing by the visiting nurse three times a week and by him on other days with a large-print guide; heel offloading shoe; podiatry within two days; review weekly; a vascular surgery opinion if it is not healing within four weeks or the ankle-brachial index is very low",
        "status": "completed",
        "guideline_ids": [
          "GL-IWGDF-2023",
          "GL-ACC-PAD-2024",
          "GL-ADA-RETFOOT-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic wound plan decided at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-08-17"
      },
      {
        "id": "INT-009",
        "display": "On the retina specialist's advice: aflibercept injections in both eyes monthly for three doses, then treat-and-extend; panretinal photocoagulation to the right eye once the hemorrhage clears, and to the left if new vessels persist; vitrectomy if the hemorrhage does not clear within one to three months; low-vision evaluation; aspirin continued; glucose lowered gradually, and a GLP-1 receptor agonist only after the retina is stable, with retina review monthly",
        "status": "completed",
        "guideline_ids": [
          "GL-AAO-DR-2025",
          "GL-ADA-RETFOOT-2026",
          "GL-SUSTAIN6-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic eye plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-07-29"
      },
      {
        "id": "INT-010",
        "display": "Lisinopril increased to 40 mg and empagliflozin 10 mg started, with written sick-day rules; potassium and creatinine in four weeks; urine albumin at three months",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CKD-2026",
          "GL-ADA-CVD-2026",
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and heart plan decided at the two-day review.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-07-29"
      },
      {
        "id": "INT-011",
        "display": "Peripheral artery disease: supervised exercise therapy three times a week for twelve weeks once the heel has healed; podiatry every two to three months; vascular review if walking does not improve or any wound fails to heal",
        "status": "completed",
        "guideline_ids": [
          "GL-ACC-PAD-2024",
          "GL-IWGDF-2023",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic leg plan decided after the ankle-brachial index.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-08-26"
      },
      {
        "id": "INT-012",
        "display": "Dulaglutide 0.75 mg weekly started with the retina specialist's agreement, rising only if the retina stays stable at monthly review; ezetimibe 10 mg added; lipids four to eight weeks after the change, booked before he leaves the clinic",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-PHARM-2026",
          "GL-ADA-CVD-2026",
          "GL-SUSTAIN6-2016",
          "GL-AAO-DR-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic steps decided at the three-month review.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-10-26"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-ADA-GLY-2026",
        "title": "6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358894/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-PHARM-2026",
        "title": "9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358900/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-CVD-2026",
        "title": "10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358899/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-CKD-2026",
        "title": "11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358881/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-RETFOOT-2026",
        "title": "12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358886/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-BEH-2026",
        "title": "5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358898/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AAO-DR-2025",
        "title": "Diabetic Retinopathy Preferred Practice Pattern",
        "publisher": "American Academy of Ophthalmology (Ophthalmology 2025; Lim JI, et al.)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39918521/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-SUSTAIN6-2016",
        "title": "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6)",
        "publisher": "New England Journal of Medicine (Marso SP, et al.)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/27633186/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-ACC-PAD-2024",
        "title": "2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease",
        "publisher": "American College of Cardiology and American Heart Association (Circulation 2024)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38743805/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-AHA-CCD-2023",
        "title": "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease",
        "publisher": "American Heart Association and American College of Cardiology (Circulation 2023)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37471501/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-AHA-STROKE-2021",
        "title": "2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack",
        "publisher": "American Heart Association and American Stroke Association (Stroke 2021)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34024117/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-AHA-HTN-2025",
        "title": "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults",
        "publisher": "American Heart Association and American College of Cardiology (J Am Coll Cardiol 2025)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40815242/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-KDIGO-CKD-2024",
        "title": "KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney International)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38490803/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-IWGDF-2023",
        "title": "Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update)",
        "publisher": "International Working Group on the Diabetic Foot (Diabetes Metab Res Rev 2024)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37243927/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-PROSTATE-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the urgency of the retina visit, the anti-VEGF and laser sequence, the gradual glucose plan and the timing of dulaglutide after the retina was stable, empagliflozin with lisinopril and the potassium check, the coronary work-up through a pharmacologic stress test, the ankle-brachial index and wound care, and the grief support."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Sources: SABR, the California legislature, the National Archives, a University of California article, and the Dodgers timeline. The Library of Congress, the National Baseball Hall of Fame, the Jackie Robinson Foundation, the New York Times obituary and Arnold Rampersad's biography could not be read directly."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "His son's death is stated once, without its circumstances. Grief is supported as grief; depression screening is synthetic and below the threshold for a safety assessment, and the 988 line is named in the plan. No mental health diagnosis is made."
    }
  }
}
